Jinhe Biotechnology CO., LTD. Stock price

Equities

002688

CNE100001HK7

Pharmaceuticals

End-of-day quote Shenzhen S.E. 07:00:00 2024-03-17 pm EDT 5-day change 1st Jan Change
3.83 CNY +1.86% Intraday chart for Jinhe Biotechnology CO., LTD. +6.09% -20.37%
Sales 2021 2.08B 289M Sales 2022 2.12B 295M Capitalization 3.87B 538M
Net income 2021 94M 13.06M Net income 2022 75M 10.42M EV / Sales 2021 2.54 x
Net Debt 2021 490M 68.13M Net Debt 2022 1.11B 154M EV / Sales 2022 2.35 x
P/E ratio 2021
43.8 x
P/E ratio 2022
53.1 x
Employees 2,292
Yield 2021 *
-
Yield 2022
1.95%
Free-Float 53.74%
More Fundamentals * Assessed data
Dynamic Chart
Jinhe Biotechnology CO., LTD. announces an Equity Buyback for CNY 100 million worth of its shares. CI
Jinhe Biotechnology CO., LTD. authorizes a Buyback Plan. CI
Jinhe Biotechnology Chairman Proposes Buyback of Up to 100 Million Yuan Shares MT
Jinhe Biotechnology Gets Nod for Live Brucellosis Vaccine MT
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Jinhe Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 05 June 2023 CI
Jinhe Biotechnology CO., LTD. announced that it expects to receive CAD 124.8 million in funding from Jinhe Youben Biological Products Co., Ltd. CI
Jinhe Biotechnology CO., LTD. Announces Board Election CI
Jinhe Biotechnology CO., LTD. Approves Cash Dividend (Tax Included) for 2022 CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jinhe Biotechnology Co., Ltd. Announces Final Profit Distribution Proposal for 2022 CI
Jinhe Biotechnology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tranche Update on Jinhe Biotechnology CO., LTD.'s Equity Buyback Plan announced on May 26, 2022. CI
Jinhe Biotechnology to Take Full Control of Environmental Protection Firm For $46 Million MT
More news
1 day+1.86%
1 week+6.09%
Current month+4.93%
1 month+17.13%
3 months-21.68%
6 months-21.52%
Current year-20.37%
More quotes
1 week
3.66
Extreme 3.66
3.84
1 month
3.33
Extreme 3.33
3.97
Current year
2.91
Extreme 2.91
4.98
1 year
2.91
Extreme 2.91
5.48
3 years
2.91
Extreme 2.91
7.51
5 years
2.91
Extreme 2.91
9.68
10 years
2.91
Extreme 2.91
13.28
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 98-12-31
Director of Finance/CFO 53 07-12-31
Director/Board Member 50 91-12-31
Members of the board TitleAgeSince
Director/Board Member 57 20-06-01
Director/Board Member 60 -
Director/Board Member 50 91-12-31
More insiders
Date Price Change Volume
24-03-18 3.83 +1.86% 8,326,999
24-03-15 3.76 +1.35% 6,629,243
24-03-14 3.71 -0.80% 6,060,400
24-03-13 3.74 0.00% 9,352,300
24-03-12 3.74 +3.60% 10,834,200

End-of-day quote Shenzhen S.E., March 17, 2024

More quotes
Jinhe Biotechnology CO., LTD. is a China-based company principally engaged in the research, development, production and sale of pharmaceutical feed additives. The Company's main products include animal feed additives, veterinary drug additives, veterinary vaccines and veterinary drugs. The Company is also involved in processing of corn starch, as well as wastewater treatment business. The Company distributes its products in domestic market and to overseas markets.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Jinhe Biotechnology CO., LTD. - Shenzhen S.E.